| RS1253072668 |
MYT1L
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 39 |
| RS1253114701 |
TSPEAR
|
Health Risk |
Pathogenic |
Ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis |
| RS1253117981 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1253123816 |
NF1
|
Health Risk |
Likely pathogenic |
— |
| RS1253128772 |
SMARCD1
|
Health Risk |
Likely pathogenic |
Alopecia, androgenetic |
| RS1253151209 |
BAP1
|
Health Risk |
Pathogenic |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1253152691 |
HUWE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1253153154 |
KIF7
|
Health Risk |
Pathogenic/Likely pathogenic |
Acrocallosal syndrome, Hydrolethalus syndrome 2 |
| RS1253161767 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1253171024 |
MYL4
|
Health Risk |
Likely pathogenic |
Atrial fibrillation, familial |
| RS1253171657 |
PIK3CA
|
Health Risk |
Conflicting classifications of pathogenicity |
Cowden syndrome, Cowden syndrome |
| RS1253188873 |
IFT140
|
Health Risk |
Pathogenic |
IFT140-related disorder, Renal cyst |
| RS1253211384 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy |
| RS1253227059 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1253246966 |
ZNF292
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder, autosomal dominant 64 |
| RS1253275403 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1253284091 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1253286238 |
RBP3
|
Health Risk |
Pathogenic |
— |
| RS1253289234 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS1253289854 |
DOK7
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 10, Fetal akinesia deformation sequence 1 |
| RS1253293795 |
PCARE
|
Health Risk |
Pathogenic |
— |
| RS1253324101 |
AGA
|
Health Risk |
Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS1253347170 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1253353417 |
RARS2
|
Health Risk |
Likely pathogenic |
— |
| RS1253383921 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Familial hypobetalipoproteinemia 1 |
| RS1253403779 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1253404236 |
POLG2
|
Health Risk |
Pathogenic |
— |
| RS1253419936 |
CDH23
|
Health Risk |
Pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS1253447533 |
POMT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2 |
| RS1253458479 |
HPS5
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome, Hermansky-Pudlak syndrome 5 |
| RS1253470807 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS1253481641 |
KCNQ3
|
Health Risk |
Conflicting classifications of pathogenicity |
Benign neonatal seizures, Benign neonatal seizures |
| RS1253496792 |
XPA
|
Health Risk |
Likely pathogenic |
Xeroderma pigmentosum group A, Xeroderma pigmentosum group A |
| RS1253499013 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral arteriopathy, autosomal dominant |
| RS1253502123 |
NBAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Short stature-optic atrophy-Pelger-Huët anomaly syndrome, Infantile liver failure syndrome 2 |
| RS1253505269 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1253517114 |
POLG
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive sclerosing poliodystrophy, Mitochondrial DNA depletion syndrome 4b |
| RS1253531908 |
TWNK
|
Health Risk |
Pathogenic |
Third degree atrioventricular block, Third degree atrioventricular block |
| RS1253558458 |
CTNNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, CTNNA1-related disorder |
| RS1253568005 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1253568733 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1253582681 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1253596843 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1253611243 |
IMPG2
|
Health Risk |
Likely pathogenic |
— |
| RS1253612362 |
MYO15A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS1253622274 |
ILK
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial hypertrophic cardiomyopathy, Primary familial hypertrophic cardiomyopathy |
| RS1253630975 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1253680250 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1253689023 |
NEK10
|
Health Risk |
Likely pathogenic |
Ciliary dyskinesia, primary |
| RS1253708943 |
ALG1
|
Health Risk |
Pathogenic |
ALG1-congenital disorder of glycosylation, ALG1-congenital disorder of glycosylation |
| RS1253749894 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS12537531 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 7 |
| RS1253756196 |
CERS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive myoclonic epilepsy type 8, Progressive myoclonic epilepsy type 8 |
| RS1253789424 |
BBS7
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 7, Bardet-Biedl syndrome |
| RS1253790930 |
FAM161A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 28, Retinal dystrophy |
| RS1253799389 |
MCFD2
|
Health Risk |
Pathogenic |
Factor 5 and Factor VIII, combined deficiency of |
| RS1253807820 |
KIAA0586
|
Health Risk |
Pathogenic |
Joubert syndrome 23, Short-rib thoracic dysplasia 14 with polydactyly |
| RS1253817401 |
NPHP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Nephronophthisis |
| RS1253822191 |
POLR3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukodystrophy, hypomyelinating |
| RS1253866874 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1253870232 |
NAGLU
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis |
| RS1253878709 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Papillary renal cell carcinoma type 1, Renal cell carcinoma |
| RS1253882360 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1253904315 |
RAD50
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1253918930 |
SLC7A7
|
Health Risk |
Conflicting classifications of pathogenicity |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS1253923818 |
OPHN1
|
Health Risk |
Pathogenic |
— |
| RS1253927514 |
DNAJC3
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1253942262 |
ARSG
|
Health Risk |
Pathogenic |
Usher syndrome, type 4 |
| RS1253943370 |
MYO7A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 2, Usher syndrome type 1 |
| RS1253945933 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia |
| RS1253951128 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1253964609 |
ACTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1253978998 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Amyotrophic lateral sclerosis type 4 |
| RS1253988919 |
RPGRIP1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1253993053 |
LEPR
|
Health Risk |
Conflicting classifications of pathogenicity |
Obesity due to leptin receptor gene deficiency, Obesity due to leptin receptor gene deficiency |
| RS1253995342 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1253995767 |
CLDN16
|
Health Risk |
Pathogenic |
Primary hypomagnesemia, Primary hypomagnesemia |
| RS1254002019 |
SUFU
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Gorlin syndrome |
| RS1254008304 |
ERCC6
|
Health Risk |
Pathogenic |
Cerebrooculofacioskeletal syndrome 1, DE SANCTIS-CACCHIONE SYNDROME |
| RS1254014649 |
ABCA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pulmonary alveolar proteinosis, Hereditary pulmonary alveolar proteinosis |
| RS1254024310 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS1254052531 |
SDHAF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary pheochromocytoma and paraganglioma |
| RS1254059410 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1254063262 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism type 1C, Pseudohypoparathyroidism type 1C |
| RS1254094658 |
PACS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 66 |
| RS1254096311 |
RDH12
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis |
| RS1254101861 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS1254121532 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome due to tenascin-X deficiency, Ehlers-Danlos syndrome |
| RS1254126085 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS1254126467 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 7 |
| RS1254158201 |
SQSTM1
|
Health Risk |
Pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 1, Paget disease of bone 2 |
| RS1254164861 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Cardiomyopathy |
| RS1254176854 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Carcinoma of colon, Familial adenomatous polyposis 1 |
| RS1254191370 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS1254210696 |
ERCC2
|
Health Risk |
Likely pathogenic |
— |
| RS1254257945 |
PROC
|
Health Risk |
Likely pathogenic |
Reduced protein C activity, Reduced protein C activity |
| RS1254261817 |
WFS1
|
Health Risk |
Pathogenic |
— |
| RS1254264958 |
GREB1L
|
Health Risk |
Likely pathogenic |
Male infertility with azoospermia or oligozoospermia due to single gene mutation, Male infertility with azoospermia or oligozoospermia due to single gene mutation |
| RS1254271466 |
ASXL1
|
Health Risk |
Pathogenic |
Bohring-Opitz syndrome, Bohring-Opitz syndrome |
| RS1254300059 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |